Drug Development Snapshot
Total Page:16
File Type:pdf, Size:1020Kb
BIOTECH PRIMER’S COURSE SNAPSHOT Drug Development Drug Development Live, Online Master Courses Choose from our prescheduled, signature courses or let us customize the course based on your needs and bring it onsite to your organization. Drug Discovery for the Scientist one-day course ����������������������������������������������������4 Preclinical Development for the Scientist one-day course ...................................6 Drug Development Immersion two-day course �������������������������������������������������������8 Understanding Commercialization Within Biopharma two-day course �����������11 On-Demand Master Course Recordings Cannot make our live, online class? Take the same class but in its recorded version. Same content, interactive exercises, and course material. Depending on the length of the course you have 1-3 months to view. Drug Development Immersion 9-hour course.......................................................14 On-Demand, Online Classes Learn anywhere, at your own pace. Designed for individuals, customized for organizations. The Regulatory Process 60-minute online class .......................................................18 Drug Discovery of Small Molecules 55-minute online class �����������������������������������20 Drug Discovery of Biologics 45-minute online class ................................................21 Preclinical Development 55-minute online class .....................................................22 Clinical Development 101: General Principles 55-minute online class ����������������23 BiotechPrimer.com BIOTECH PRIMER, INC. COPYRIGHT 2021 | 2 On-Demand, Online Classes (continued) Clinical Development 201: Phase I 50-minute online class ................................... 24 Clinical Development 301: Phase II/III 55-minute online class ������������������������������25 Clinical Development 401: Phase IV 50-minute online class ����������������������������������26 For more information contact Stacey Hawkins T. 410.377.4429 [email protected] Class registration @ BiotechPrimer.com BiotechPrimer.com BIOTECH PRIMER, INC. COPYRIGHT 2021 | 3 Drug Discovery for the Scientist ONE-DAY LIVE, ONLINE COURSE OVERVIEW Drug Discovery for the Scientist is a one-day, intensive course specifically designed for scientists who need to better understand the drug discovery process using an application of risk assessment and multi-disciplinary approaches with considerations for how best to get medicine to patients. Learn from an industry expert what it takes to validate targets, screen molecules to select a lead candidate and to inform an investigational new drug (IND) or clinical trial (CTA) application. Five Takeaways: 1. Fluency in drug discovery process including major milestones. 2. Selection of pharmacologically relevant targets. 3. Criteria to eliminate candidates. 4. Key development considerations for antibodies, cell and gene therapies. 5. Required regulatory studies and data to enable an IND or CTA. BiotechPrimer.com BIOTECH PRIMER, INC. COPYRIGHT 2021 | 4 AGENDA Target Validation 9:00-9:45 Gene Therapy 12:45-1:15 Drug development process overview Screening systems: in silico, in vivo, in vitro Stage gates Identifying potential safety issues Survey of druggable and undruggable targets Target ID, selection, key considerations Safety: Off-Target Screening 1:15-1:45 Target platforms and libraries Screening systems: in silico, in vivo, in vitro Identifying potential safety issues Break 9:45-10:00 Break 1:45-2:00 Lead Optimization 10:00-11:15 How to prioritize leads Analytical and Bioanalytical Assays High-throughput screening techniques 2:00-2:30 How to eliminate candidates Assay development Affinity maturation, antibody diversity Assay validation IgG subtype, alternate formats Supporting cGMPs and GLP Packet Insert Activity 11:15-11:30 Enabling Clinical Trials 2:30-3:15 Quality Cell-Based Therapy 11:30-12:00 Pharmacology Screening systems: in silico, in vivo, in vitro Pharmacokinetics Identifying potential safety issues Toxicology Required studies/data to enable IND/CTA Lunch 12:00-12:45 Wrap-Up 3:15-3:30 BiotechPrimer.com BIOTECH PRIMER, INC. COPYRIGHT 2021 | 5 Preclinical Development for the Scientist ONE-DAY COURSE OVERVIEW Preclinical Development for the Scientist is a one-day, fast-paced course specifically designed for scientists who need to better understand the regulatory requirements of preclinical development. Learn from an industry expert the approaches and criteria used to support a development candidate’s nomination for an IND or CTA to enable first-in-human studies. Five Takeaways: 1. Fluency in preclinical/nonclinical development including required milestones. 2. Typical approaches and criteria used to support development candidate nominations for first- in-human trials. 3. Species selection and use of animal pharmacokinetics in describing the expose-response relationships. 4. Importance of toxicology in selecting compounds and establishing safety. 5. Estimating safe starting dose levels for clinical trials. BiotechPrimer.com BIOTECH PRIMER, INC. COPYRIGHT 2021 | 6 AGENDA CMC 9:00-9:45 Lunch 12:15-1:00 Upstream and downstream bulk processing Cell line and cell bank development Non-Clinical Development Considerations Formulation, fill and finish in Pre-IND/IND 1:00-1:45 Stability and analytical testing of protein Quality products Pharmacology, pharmacokinetics and toxicology Pharmacology 9:45-10:45 Required regulatory studies/data to enable Required data including publications IND/CTA Binding, potency, receptor occupancy Efficacy improvement Break 1:45-2:00 Qualitative and quantitative endpoints In vitro and in vivo models Integrated Development 2:00-2:45 Packaging CMC/nonclinical/clinical data for Break 10:45-11:00 IND Pharmacokinetics 11:00-11:30 IND Requirements 2:45-3:15 Absorption, distribution, metabolism, IND components elimination Common technical document format PK/PD, exposure-response relationships Regulatory process Noncompartmental analysis, AUC, Cmax Wrap-Up 3:15-3:30 Toxicology 11:30-12:15 Criteria to support candidate nomination Dose level selection, routes of administration Species selection, therapeutic margins Defining adverse effects Estimating safe starting dose levels BiotechPrimer.com BIOTECH PRIMER, INC. COPYRIGHT 2021 | 7 Drug Development Immersion LIVE, ONLINE | LEVEL ONE OVERVIEW Drug Development Immersion is a two-day, interactive course that explores the regulatory, commercial, and scientific factors that enable a drug to be successfully brought to market. Discussion features both small molecule drugs and biologics. Our instructors illustrate the corporate decision-making process with personal accounts, giving participants unique insight into strategic development. Learn from an industry expert what it takes to get a molecule from the bench into the marketplace. Drug Development Immersion was developed for the non-science professional who works within or services the biopharma industry. Five Takeaways: 1. Fluency in essential terminology and acronyms used in clinical development 2. In-depth look at the FDA and EMA regulatory process and sponsor interactions 3. Criteria for preclinical studies to support first in human clinical trials 4. Rationale, special considerations, and study design for both traditional and non-traditional clinical trial phases 5. Understanding of the launch process, life cycle management, and post-approval drug safety monitoring BiotechPrimer.com BIOTECH PRIMER, INC. COPYRIGHT 2021 | 8 AGENDA DAY ONE Break 2:00-2:15 Introductions 9:00-9:15 Preclinical Development 2:15-3:15 Setting the Stage 9:15-10:30 Preclinical development pre-IND/CTA Small and large molecule drug characteristics Preclinical data objectives Desirable drug characteristics Safety testing terms Agonist and antagonist drugs Nonclinical studies Route of administration based on drug type Toxicology, pharmacology, pharmacokinetics Traditional drug development pathway IND/CTA filings Gene and cell therapy development pathway Authorization to proceed to clinical trials Drug development metrics Chances of success, timelines and costs Wrap-Up 3:15-3:30 Break 10:30-10:45 The Business of Drug Development 10:45-12:00 Integrated drug development process Stage gates- go/no go decisions Target product profile Draft label Breakout room: draft label activity US patents and market exclusivity Lunch 12:00-12:45 The Regulatory Process 12:45–2:00 Regulatory agencies and compliance worldwide PDUFA, GDUFA, BsUFA Generics and biosimilars approval pathways FDA/sponsor meeting timeline FDA expedited programs Voucher system FDA and EMA orphan drug designation EMA user fees and review times EMA expedited reviews and designations FDA and EMA approval process Regulatory Compliance BiotechPrimer.com BIOTECH PRIMER, INC. COPYRIGHT 2021 | 9 DAY TWO Clinical Development Phase II 1:15-2:00 The Players: Who is involved? 9:00-9:45 Purpose of Phase II Subjects, sponsors, investigators Phase IIA and IIB Ethics committees/investigational review Randomized control trials board Statistical considerations Informed consent Null hypothesis, P value, type 1 and 2 errors Contract research organizations Breakout Room: intro to clinical statistics activity Patient advocacy groups Data monitoring committees (DMC) Clinical Development Phase III 2:00-2:45 How DMC impacts clinical trials Purpose of Phase III Phase IIIB General Principles: Ethics and Risk Trial designs: parallel, crossover, adaptive 9:45-10:30 Database cleaning, lock and unblinding Risk assessment and management Regulatory application submittal